Dr. William F. DeGrado, a Discoverer of Brilacidin, Joins Innovation Pharmaceuticals as Scientific Advisor

    NEXT STORY
    Immunoassays – Worldwide Industry Analysis (2019-2023) with Profiles of 44 Companies
    PREV STORY
    Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    LIDDS signs license agreement for prostate cancer drug Liproca® Depot with major Chinese pharma company

    UPPSALA, SWEDEN - LIDDS AB (publ) has signed a license agreement for Liproca® Depot ...

    author_avatar
    NASDAQ Market News

    One Medical extends public COVID-19 vaccination efforts to additional communities in partnerships with departments of public health

    author_avatar
    NASDAQ Market News

    CB2 Insights Selected by Vireo Health to Support Medical Cannabis Clinical Trial

    author_avatar
    NASDAQ Market News